GLP-1 medications like semaglutide and tirzepatide have changed weight management, helping many people lose a significant share of their body weight. A natural question follows: if you stop taking one, will the weight come back? Here is an honest look at what the research shows and what helps.
What happens when you stop
While on semaglutide or tirzepatide, you eat less, feel full sooner, and experience fewer cravings. When the medication stops, those effects fade. Appetite returns toward its baseline, and the body tends to push you to eat more. Regaining some weight is a common, physiological response, not a matter of willpower, because the appetite-regulating signal the medication provided is gone.
What the research shows
Most people regain a meaningful portion of lost weight after stopping. In the STEP-1 trial extension, participants regained about two-thirds of their prior weight loss within a year of stopping semaglutide, and much of the improvement in cardiometabolic markers reversed as well.[1] Trials of tirzepatide have shown a similar pattern: continued treatment maintains weight loss, while stopping leads to partial regain. This is one reason obesity is increasingly treated as a chronic condition that may need ongoing management.
Challenges to expect
- Appetite and cravings return.
- Metabolism runs lower at a smaller body size, so maintenance takes fewer calories.
- Old habits can resurface without structure.
- Emotional or stress eating may become more prominent.
Strategies that help you hold your progress
Talk to your clinician before stopping
Do not stop abruptly on your own. Your clinician may taper your dose or discuss a maintenance approach, which can soften the return of hunger.
Eat for satiety
Prioritize protein and fiber, which help you feel full as natural hunger cues return.
Keep portions in check
Tracking your intake for a few weeks after stopping helps you catch drift early.
Stay active
Regular activity, including strength training to preserve muscle, supports maintenance. Many guidelines suggest working toward roughly 200 to 300 minutes of moderate activity per week for weight maintenance.
Protect sleep and manage stress
Short sleep and high stress raise hunger hormones. Aim for adequate sleep and find stress-relief strategies that work for you. See our guide on sleep and weight loss.
Stay accountable
Regular check-ins, weekly weigh-ins, and clear action thresholds help you respond to small regains before they grow.
Be open to ongoing treatment
Because obesity is chronic, some people do best with long-term or intermittent medication. That is a clinical decision, not a personal failure.
How IVUSE+ supports the transition
At IVUSE+, treatment is managed by licensed clinicians through async telehealth. If you are considering coming off a GLP-1, your clinician can help plan a taper or a maintenance dose, adjust your protocol based on how you respond, and monitor your progress. You can learn more about compounded semaglutide and compounded tirzepatide, or review our guide on dietary considerations for eating well during and after treatment.
References
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553-1564.
This article is for general education and is not medical advice. Do not start or stop any medication without a licensed clinician. Compounded medications are not FDA-approved.
